scorecardresearch
Add as a preferred source on Google
Tuesday, December 23, 2025
TopicBiocon

Topic: Biocon

Serum Institute to double investment in Biocon’s unit to $300 million

Under new terms of the alliance, it would pump in $150 million after converting a loan to Biocon Pharma Ltd into equity in Biocon Biologics Ltd, the company said.

CBI alleges bribery in Biocon injection clearance, company says ‘approvals legitimate’

In a statement Monday, Biocon Biologics spokesperson said the injection is approved in Europe & many other countries. CBI has booked joint drug controller, Biocon executives in the case.

Biocon partners SII to make vaccine, drug manufacturing accessible to developing nations

Under the deal, Biocon Biologics Ltd (BBL) will offer approximately 15% stake to Serum Institute Life Sciences at a post-money valuation of about Rs 35,000 crore.

Biocon Biologics joins Novartis, Pfizer to distribute cancer drugs in lower-income countries

Biocon Biologics partnered with international organisations to enhance access to life-saving cancer drugs for patients, especially in Sub-Saharan and Asian regions.

Monitor efficacy of Itolizumab, not just safety, in Covid trials — expert panel tells Biocon

Govt's expert panel, that advises the apex drug regulator, has asked Biocon to submit a revised proposal for phase 4 trials of Itolizumab, which already has emergency use approval.

In Covid quarantine, Netflix, Amazon Prime were my constant companions: Kiran Mazumdar Shaw

I was expecting the infection to be mild and short-lived. My Covid-19 experience has matched these expectations and I hope that it allays the fear of the virus.

Biocon to give more data on Itolizumab to Covid task force after its rejection for treatment

The company said it would share more data as ‘evidence’, which it has derived from off-label use of the drug on 1,000 patients.

Task force decides against including Itolizumab in clinical management protocols for Covid

Itolizumab was approved for 'restricted emergency use' in the treatment of coronavirus by the Drugs Controller General of India (DCGI) recently.

30 patients, 2 months — how Biocon claims to have found a Covid hope in itolizumab

The drug controller general of India (DCGI) had Saturday approved Biocon’s itolizumab for emergency, restricted use among severe Covid-19 patients.

All about Biocon’s Itolizumab, psoriasis drug approved for emergency use in Covid patients

DGCI has given 'restricted emergency use' approval to the drug for treating Covid-19 patients with moderate-to-severe acute respiratory distress.

On Camera

Goa’s new favourite bar isn’t chasing tourists. It’s fiercely local

A little over a year into operation, after opening in early 2024, Grumps has become one of Goa’s most coveted dining destinations.

To meet fund crunch, Karnataka to auction plots in Bengaluru, raise Rs 4,000 crore

Siddaramaiah govt’s five schemes strain finances as GST changes hit revenues; debt to jump nearly Rs 80,000 crore. State also plans to auction liquor licences & extend bar timings.

Turkiye delivers second MILGEM-class corvette Khaibar to Pakistan Navy, two others in making

Contract for construction of four MILGEM-class ships was signed in 2018. PNS Bedir is to be delivered by June 2026, while PNS Tariq is due for delivery in first quarter of 2027.

Dhurandhar shows hard cinema is soft power and Pakistan is unapologetically the target

If Pathaan gave both conservatives and liberals room to hide, Dhurandhar extends no such courtesy. Aditya Dhar ripped open that tent of hypocrisy and turned the knife.